Showing results (241-250 of 588) with videos related to

Sort By:
Pageof 59
Cancer Research|September 24, 2009
MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagyBala S Balakumaran, Alessandro Porrello, David S Hsu, et al.
Molecular Cancer Research : MCR|January 7, 2017
Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor MicroenvironmentLisa Staunton, Claire Tonry, Rosina Lis, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 31, 2025
Antibody-Based Multiplex Image Analysis: Standard Analytical Workflows and Artificial Intelligence Tools for PathologistsMohamed Omar, Giuseppe Nicolo' Fanelli, Fabio Socciarelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2023
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association StudyChaoran Ma, Xiaoyu Wang, James Y Dai, et al.
The Journal of Biological Chemistry|April 2, 2005
Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp miceTerence M Williams, Ghada S Hassan, Jiangwei Li, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosisKiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, et al.
JAMA Oncology|May 30, 2020
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical TrialToni K Choueiri, Daniel Y C Heng, Jae Lyun Lee, et al.
BMC Cancer|August 8, 2021
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinomaThomas Powles, Toni K Choueiri, Robert J Motzer, et al.
Virchows Archiv : an International Journal of Pathology|March 21, 2007
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinomaShuji Ogino, Jeffrey A Meyerhardt, Takako Kawasaki, et al.
The Journal of Clinical Endocrinology and Metabolism|April 27, 2016
Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer ProgressionThomas U Ahearn, Nairi Tchrakian, Kathryn M Wilson, et al.
Pageof 59